# Ritalin

NDC: 0078-0441
Generic name: methylphenidate hydrochloride
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 19551231
Marketing ended: 20260831
FDA application: NDA010187

## Active ingredients

- METHYLPHENIDATE HYDROCHLORIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0441"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0441
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0bf0835-6a2f-4067-a158-8b86c4b0668a